Feed SPNRF
Summary
35 / 100 · Bulios Score
Valuation 51Growth 46Profitability -Quality 0Debt 49Stability 34
What speaks for it
- The price moves less than the market (beta 0.62).
What to watch
- It passes only 2 of the 9 points of the Piotroski financial health test.
- For every 100 CAD of bills due within a year it has 62 CAD of short-term assets.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedIs it growing?
SlowlyRevenue (CAD)
20212022202320242025
Diluted EPS (CAD)
20212022202320242025
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Debt is a burdenCash and short-term investments $869.0
Debt $127.4K
Free cash flow over 12 months -$171.5K
Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.